We are live on ! Find out more
SMTI icon

Sanara MedTech

58 hedge funds and large institutions have $36.1M invested in Sanara MedTech in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

15% more capital invested

Capital invested by funds: $31.4M → $36.1M (+$4.68M)

12% more funds holding

Funds holding: 5258 (+6)

0.33% more ownership

Funds ownership: 12.45%12.78% (+0.33%)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
58
Holders Change
+6
Holders Change %
+11.54%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
13
Reduced
21
Closed
7
Calls
Puts
Net Calls
Net Calls Change

SMTI Hedge Fund Activity: Q3 2025 in Review

58 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2025, worth a combined $36.1M — up 15% from $31.4M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new SMTI positions and 7 closed out — a net gain of 6 holders — while 13 added to existing stakes and 21 trimmed.

The largest buyer was Squarepoint, adding an estimated $734K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $263K sold.

  • 58 institutional investors held Sanara MedTech (SMTI) as of Q3 2025, up from 52 in Q2 2025.
  • Funds reported $36.1M of Sanara MedTech stock for Q3 2025, up 15% quarter-over-quarter.
  • 13 funds opened new Sanara MedTech positions in Q3 2025 and 7 closed out, a net change of +6 holders.
  • The largest Sanara MedTech buyer in Q3 2025 was Squarepoint, an estimated $734K added.
  • The largest Sanara MedTech seller in Q3 2025 was Susquehanna International Group, an estimated $263K sold.

Based on aggregated 13F filings for Q3 2025.